Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits
-
Published:2023
Issue:4
Volume:51
Page:956-960
-
ISSN:1073-1105
-
Container-title:Journal of Law, Medicine & Ethics
-
language:en
-
Short-container-title:J. Law. Med. Ethics
Author:
White Erica N.,Saxon Mary,Hodge James G.,Michaels Joel
Abstract
AbstractA series of structural constitutional arguments lodged in multiple cases against Centers for Medicare and Medicaid Services’ (CMS) authorities to negotiate prescription drug prices via the 2022 Inflation Reduction Act threaten the legitimacy of CMS program and federal agency powers.
Publisher
Cambridge University Press (CUP)